SB 15 (2017): relative to the law regarding therapeutic use of cannabis.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA: “SB 15 (2017): relative to the law regarding therapeutic use of cannabis.” Granite Record, https://graniterecord.org/bill/2017/sb15. Accessed 24 Oct. 2026.
APA: Granite Record. (n.d.). SB 15 (2017): relative to the law regarding therapeutic use of cannabis. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2017/sb15
Chicago: Granite Record. “SB 15 (2017): relative to the law regarding therapeutic use of cannabis.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2017/sb15.
BibTeX: @misc{bill-2017-sb15, title = {SB 15 (2017): relative to the law regarding therapeutic use of cannabis.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2017/sb15}, note = {Accessed 24 Oct. 2026} }

SB 15 (2017)

relative to the law regarding therapeutic use of cannabis.

Status: Died on the table
Term: 2017-2018
House committee: Health, Human Services and Elderly Affairs
Senate committee: Health and Human Services
Subject: Public and Mental Health

The Story

It was introduced on January 5, 2017 and referred to the Senate Health and Human Services committee. The committee held a public hearing on January 10, 2017. The committee recommended that the Senate pass it. A floor amendment (2017-0048s), offered by Sen. Bradley, was withdrawn. On January 19, 2017 the Senate voted to pass it on a voice vote and ordered it to a third reading. It crossed to the House on February 16, 2017 and was referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on March 21, 2017. The committee met in executive session on March 22, 2017 to vote on its recommendation. The committee voted 17–2 to recommend that the House pass it, and the report was placed on the regular calendar. On April 20, 2017 the House voted to pass it on a voice vote. On May 4, 2017 the House adopted “Reconsider SB 15” on a voice vote, on a motion by Rep. Cushing. On May 4, 2017 the House voted to lay it on the table on a voice vote, on a motion by Rep. Kotowski.

Hearings and Sessions

January 10, 2017, 1:30 PM: hearing, Senate Health and Human Services, LOB 101
March 21, 2017, 10:00 AM: public hearing, House Health, Human Services and Elderly Affairs, LOB 205
March 22, 2017, 9:00 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 205

Votes

January 19, 2017, Senate: Ought to Pass — voice vote, passed
April 20, 2017, House: Ought to Pass — voice vote, passed
May 4, 2017, House: Reconsider SB 15 — voice vote, passed
May 4, 2017, House: Lay on Table — voice vote, passed

The Docket

January 5, 2017: To Be Introduced 01/05/2017 and Referred to Health and Human Services
January 10, 2017: Hearing: 01/10/2017, Room 101, LOB, 01:30 pm
January 19, 2017: Committee Report: Ought to Pass, 01/19/2017
January 19, 2017: Sen. Bradley Offered Floor Amendment #2017-0048s ; 01/19/2017
January 19, 2017: Sen. Bradley Withdraws Floor Amendment 2017-0048s; 01/19/2017
January 19, 2017: Ought to Pass : MA, VV; OT3rdg; 01/19/2017
February 16, 2017: Introduced 02/16/2017 and referred to Health, Human Services and Elderly Affairs
March 21, 2017: Public Hearing: 03/21/2017 10:00 AM LOB 205
March 22, 2017: Executive Session: 03/22/2017 09:00 AM LOB 205
April 20, 2017: Committee Report: Ought to Pass for 04/20/2017 (Vote 17-2; RC)
April 20, 2017: Ought to Pass : MA VV 04/20/2017
May 4, 2017: Reconsider SB 15 (Rep. Cushing): MA VV 05/04/2017
May 4, 2017: Lay on Table (Rep. Kotowski): MA VV 05/04/2017
November 30, 2017: Died on Table

Laws It Would Change

RSA 126-X:1

Related Bills

HB 157 (2017): adding chronic pain to qualifying conditions under therapeutic use of cannabis.
HB 160 (2017): relative to use of cannabis for therapeutic purposes.
HB 157 (2017): adding chronic pain to qualifying conditions under therapeutic use of cannabis.